The Global Neurovascular Devices/Interventional Neurology Market size was valued at USD 4693 Mn. in 2024, and the Global Neurovascular Devices/Interventional Neurology Market revenue is expected to grow at a CAGR of 5.2% from 2025 to 2032, reaching nearly USD 7040 Mn.Global Neurovascular Devices/Interventional Neurology Market introduction and Overview
Neurovascular/interventional neurology devices are used to treat several neurovascular diseases (including aneurysms, arteriovenous malformations and atherosclerosis) that affect the central nervous system as well as the blood vascular system associated with it. Therapeutic procedures are increasingly being adopted for better diagnosis, monitoring and therapy for neurological conditions because of their proven efficacy. This is one of the major reasons for increasing adoption of interventional neurology products. These products are adopted globally by majority of neurosurgeons and medical professionals in key markets such as the U.S, Germany, France and UK. Significant consumption value of neurovascular devices and rapidly growing patient population are expected to boost the market growth. The increasing prevalence of cancers, strokes and other malformations has made the innovation of advanced technologies mandatory. Changing sedentary lifestyle, high blood pressure, smoking, obesity are resulting in rising cases of neurological or neurovascular diseases.To know about the Research Methodology :- Request Free Sample Report According to a country wise analysis, the number of cases of brain aneurysm and ischemic strokes are increasing rapidly in developing as well as developed economies. There is a rise in demand for minimally invasive surgical procedures, also technological advancements in neurovascular treatments are taking place. Moreover, government initiatives to modernize healthcare infrastructure across the globe are also expected to drive the market upwards. All the above mentioned factors are responsible for the Neurovascular Devices/Interventional Neurology Market to grow at a rapid pace in the forecast period. However, the chief markets such as the U.S., Germany, and Japan have a limited number of neurosurgeons with the required skills and experience to perform surgical clipping or endoscopy to treat complex cerebral aneurysms. In terms of providing training, healthcare providers across these markets have been unable to match the ongoing technological advancements and expansion of patient base. Thus, the inadequacy of skilled and experienced neurosurgeons is restraining the adoption of neurovascular devices/interventional neurology. The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Neurovascular Devices/Interventional Neurology Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Global Neurovascular Devices/Interventional Neurology Market Segment Analysis:
Based on End Use, The aneurysm coiling and embolization devices segment is expected to account for the largest market share of xx% in the forecast period. Coil embolization is a minimally invasive procedure to treat an aneurysm by filling it with material that closes off the sac and reduces the risk of bleeding. It is performed from "within" the artery (endovascular) through a steerable catheter inserted into the blood stream at the groin and guided to the brain. The increasing frequency of unruptured intracranial aneurysm detection and rising focus on new product launches are expected to boost the segment growth. Moreover, high demand for minimally invasive neurosurgical procedures and availability of embolic coils are also augmenting the market growth. Based on Type, the market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malfunctions and fistulas and other diseases. The ischemic stroke segment is expected to grow at a highest CAGR of xx% during the forecast period. The growing incidences of ischemic strokes and increasing preference for minimally invasive surgeries by patients, the segment is expected to grow upwards.This type of stroke is caused by a blockage in an artery that supplies blood to the brain. The blockage reduces the blood flow and oxygen to the brain, leading to damage or death of brain cells. Such strokes are treated with minimum invasive procedures such as diagnostic angiography, cerebral balloon angioplasty and stent placement.Global Neurovascular Devices/Interventional Neurology Market Regional Insights
North America generated a revenue of $xx Mn in 2023 and is expected to emerge as a dominant region in the forecast period. Increasing prevalence of strokes,rising awareness among neurosurgeons related to the benefits offered by interventional neurology devicesgrowing research activities, advanced treatment techniques and high class healthcare facilities available are boosting the market in the region. Asia Pacific is expected to witness growth in the forecast period. Owing to the increasing population and growing healthcare facilities in developing nations the market in this region is anticipated to grow. The report also helps in understanding Global Neurovascular Devices/Interventional Neurology Marketdynamics, structure by analysing the market segments and project the Global Neurovascular Devices/Interventional Neurology Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurovascular Devices/Interventional Neurology Marketmake the report investor’s guide.Neurovascular Devices/Interventional Neurology Market Scope: Inquire before buying
Neurovascular Devices/Interventional Neurology Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 4693 Mn. Forecast Period 2025 to 2032 CAGR: 5.2% Market Size in 2032: USD 7040 Mn. Segments Covered: by Product Aneurysm Coiling & Embolization Devices Embolic coils Flow diversion devices Liquid embolic agents Cerebral Balloon angioplasty and stenting systems Support devices Neurothrombectomy devices by Type Ischemic Strokes Cerebral Aneurysms Arteriovenous Malformation and Fistulas Other Disease pathology by End-use Industry Hospitals & Surgical Centers Ambulatory Care Centers Research Laboratories & Academic Institutes Neurovascular Devices/Interventional Neurology Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Neurovascular Devices/Interventional Neurology Market, Key Players
1. Stryker Corporation 2. Medtronic plc 3. Johnson & Johnson 4. Terumo Corporation 5. Penumbra, Inc 6. Abbott Laboratories 7. Merit Medical Systems, Inc 8. W.L Gore & Associates, Inc 9. Microport Scientific Corporation 10.B. Braun Melsungen AG 11.Cook 12.Uresil, LLC 13.Medikit Co Ltd 14.Bayer AG 15.Acandis GmbH 16.Biosensors International group Ltd 17.Integra Life sciences Corporation 18. OthersFrequently Asked Questions:
1. Which region has the largest share in Global Neurovascular Devices/Interventional Neurology Market? Ans: The North America region held the highest share in 2024. 2. What is the growth rate of the Global Neurovascular Devices/Interventional Neurology Market? Ans: The Global Neurovascular Devices/Interventional Neurology Market is growing at a CAGR of 5.2% during the forecasting period 2024-2030. 3. What is the scope of the Global Neurovascular Devices/Interventional Neurology Market report? Ans: The Global Neurovascular Devices/Interventional Neurology Market report helps with the PESTEL, Porter's, COVID-19 Impact analysis, Recommendations for Investors& Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global Neurovascular Devices/Interventional Neurology Market? Ans: The important key players in the Global Neurovascular Devices/Interventional Neurology Market are – Stryker Corporation, Medtronic plc, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Abbott Laboratories, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Microport Scientific Corporation, B. Braun Melsungen AG, Cook, Uresil, LLC, Medikit Co Ltd, Bayer AG, Acandis GmbH, Biosensors International Group Ltd, Integra Life Sciences Corporation, Others. 5. What is the study period of the Neurovascular Devices/Interventional Neurology Market? Ans: The Global Neurovascular Devices/Interventional Neurology Market is studied from 2024 to 2032.
1. Neurovascular Devices/Interventional Neurology Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Neurovascular Devices/Interventional Neurology Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Neurovascular Devices/Interventional Neurology Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Neurovascular Devices/Interventional Neurology Market: Dynamics 3.1. Neurovascular Devices/Interventional Neurology Market Trends by Region 3.1.1. North America Neurovascular Devices/Interventional Neurology Market Trends 3.1.2. Europe Neurovascular Devices/Interventional Neurology Market Trends 3.1.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market Trends 3.1.4. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Trends 3.1.5. South America Neurovascular Devices/Interventional Neurology Market Trends 3.2. Neurovascular Devices/Interventional Neurology Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Neurovascular Devices/Interventional Neurology Market Drivers 3.2.1.2. North America Neurovascular Devices/Interventional Neurology Market Restraints 3.2.1.3. North America Neurovascular Devices/Interventional Neurology Market Opportunities 3.2.1.4. North America Neurovascular Devices/Interventional Neurology Market Challenges 3.2.2. Europe 3.2.2.1. Europe Neurovascular Devices/Interventional Neurology Market Drivers 3.2.2.2. Europe Neurovascular Devices/Interventional Neurology Market Restraints 3.2.2.3. Europe Neurovascular Devices/Interventional Neurology Market Opportunities 3.2.2.4. Europe Neurovascular Devices/Interventional Neurology Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Neurovascular Devices/Interventional Neurology Market Drivers 3.2.3.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market Restraints 3.2.3.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market Opportunities 3.2.3.4. Asia Pacific Neurovascular Devices/Interventional Neurology Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Drivers 3.2.4.2. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Restraints 3.2.4.3. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Opportunities 3.2.4.4. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Challenges 3.2.5. South America 3.2.5.1. South America Neurovascular Devices/Interventional Neurology Market Drivers 3.2.5.2. South America Neurovascular Devices/Interventional Neurology Market Restraints 3.2.5.3. South America Neurovascular Devices/Interventional Neurology Market Opportunities 3.2.5.4. South America Neurovascular Devices/Interventional Neurology Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Neurovascular Devices/Interventional Neurology Industry 3.8. Analysis of Government Schemes and Initiatives For Neurovascular Devices/Interventional Neurology Industry 3.9. Neurovascular Devices/Interventional Neurology Market Trade Analysis 3.10. The Global Pandemic Impact on Neurovascular Devices/Interventional Neurology Market 4. Neurovascular Devices/Interventional Neurology Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 4.1.1. Aneurysm Coiling & Embolization Devices 4.1.2. Embolic coils 4.1.3. Flow diversion devices 4.1.4. Liquid embolic agents 4.1.5. Cerebral Balloon angioplasty and stenting systems 4.1.6. Support devices 4.1.7. Neurothrombectomy devices 4.2. Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 4.2.1. Ischemic Strokes 4.2.2. Cerebral Aneurysms 4.2.3. Arteriovenous Malformation and Fistulas 4.2.4. Other Disease pathology 4.3. Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 4.3.1. Hospitals & Surgical Centers 4.3.2. Ambulatory Care Centers 4.3.3. Research Laboratories & Academic Institutes 4.4. Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Region (2024-2032) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Neurovascular Devices/Interventional Neurology Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 5.1.1. Aneurysm Coiling & Embolization Devices 5.1.2. Embolic coils 5.1.3. Flow diversion devices 5.1.4. Liquid embolic agents 5.1.5. Cerebral Balloon angioplasty and stenting systems 5.1.6. Support devices 5.1.7. Neurothrombectomy devices 5.2. North America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 5.2.1. Ischemic Strokes 5.2.2. Cerebral Aneurysms 5.2.3. Arteriovenous Malformation and Fistulas 5.2.4. Other Disease pathology 5.3. North America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 5.3.1. Hospitals & Surgical Centers 5.3.2. Ambulatory Care Centers 5.3.3. Research Laboratories & Academic Institutes 5.4. North America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Country (2024-2032) 5.4.1. United States 5.4.1.1. United States Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 5.4.1.1.1. Aneurysm Coiling & Embolization Devices 5.4.1.1.2. Embolic coils 5.4.1.1.3. Flow diversion devices 5.4.1.1.4. Liquid embolic agents 5.4.1.1.5. Cerebral Balloon angioplasty and stenting systems 5.4.1.1.6. Support devices 5.4.1.1.7. Neurothrombectomy devices 5.4.1.2. United States Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 5.4.1.2.1. Ischemic Strokes 5.4.1.2.2. Cerebral Aneurysms 5.4.1.2.3. Arteriovenous Malformation and Fistulas 5.4.1.2.4. Other Disease pathology 5.4.1.3. United States Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 5.4.1.3.1. Hospitals & Surgical Centers 5.4.1.3.2. Ambulatory Care Centers 5.4.1.3.3. Research Laboratories & Academic Institutes 5.4.2. Canada 5.4.2.1. Canada Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 5.4.2.1.1. Aneurysm Coiling & Embolization Devices 5.4.2.1.2. Embolic coils 5.4.2.1.3. Flow diversion devices 5.4.2.1.4. Liquid embolic agents 5.4.2.1.5. Cerebral Balloon angioplasty and stenting systems 5.4.2.1.6. Support devices 5.4.2.1.7. Neurothrombectomy devices 5.4.2.2. Canada Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 5.4.2.2.1. Ischemic Strokes 5.4.2.2.2. Cerebral Aneurysms 5.4.2.2.3. Arteriovenous Malformation and Fistulas 5.4.2.2.4. Other Disease pathology 5.4.2.3. Canada Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 5.4.2.3.1. Hospitals & Surgical Centers 5.4.2.3.2. Ambulatory Care Centers 5.4.2.3.3. Research Laboratories & Academic Institutes 5.4.3. Mexico 5.4.3.1. Mexico Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 5.4.3.1.1. Aneurysm Coiling & Embolization Devices 5.4.3.1.2. Embolic coils 5.4.3.1.3. Flow diversion devices 5.4.3.1.4. Liquid embolic agents 5.4.3.1.5. Cerebral Balloon angioplasty and stenting systems 5.4.3.1.6. Support devices 5.4.3.1.7. Neurothrombectomy devices 5.4.3.2. Mexico Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 5.4.3.2.1. Ischemic Strokes 5.4.3.2.2. Cerebral Aneurysms 5.4.3.2.3. Arteriovenous Malformation and Fistulas 5.4.3.2.4. Other Disease pathology 5.4.3.3. Mexico Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 5.4.3.3.1. Hospitals & Surgical Centers 5.4.3.3.2. Ambulatory Care Centers 5.4.3.3.3. Research Laboratories & Academic Institutes 6. Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.2. Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.3. Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4. Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Country (2024-2032) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.1.2. United Kingdom Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.1.3. United Kingdom Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.2. France 6.4.2.1. France Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.2.2. France Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.2.3. France Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.3. Germany 6.4.3.1. Germany Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.3.2. Germany Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.3.3. Germany Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.4. Italy 6.4.4.1. Italy Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.4.2. Italy Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.4.3. Italy Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.5. Spain 6.4.5.1. Spain Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.5.2. Spain Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.5.3. Spain Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.6. Sweden 6.4.6.1. Sweden Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.6.2. Sweden Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.6.3. Sweden Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.7. Austria 6.4.7.1. Austria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.7.2. Austria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.7.3. Austria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 6.4.8.2. Rest of Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 6.4.8.3. Rest of Europe Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4. Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Country (2024-2032) 7.4.1. China 7.4.1.1. China Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.1.2. China Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.1.3. China Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.2. S Korea 7.4.2.1. S Korea Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.2.2. S Korea Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.2.3. S Korea Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.3. Japan 7.4.3.1. Japan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.3.2. Japan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.3.3. Japan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.4. India 7.4.4.1. India Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.4.2. India Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.4.3. India Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.5. Australia 7.4.5.1. Australia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.5.2. Australia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.5.3. Australia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.6. Indonesia 7.4.6.1. Indonesia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.6.2. Indonesia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.6.3. Indonesia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.7. Malaysia 7.4.7.1. Malaysia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.7.2. Malaysia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.7.3. Malaysia Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.8. Vietnam 7.4.8.1. Vietnam Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.8.2. Vietnam Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.8.3. Vietnam Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.9. Taiwan 7.4.9.1. Taiwan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.9.2. Taiwan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.9.3. Taiwan Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 7.4.10.2. Rest of Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 7.4.10.3. Rest of Asia Pacific Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 8. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 8.2. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 8.3. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 8.4. Middle East and Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Country (2024-2032) 8.4.1. South Africa 8.4.1.1. South Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 8.4.1.2. South Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 8.4.1.3. South Africa Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 8.4.2. GCC 8.4.2.1. GCC Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 8.4.2.2. GCC Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 8.4.2.3. GCC Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 8.4.3. Nigeria 8.4.3.1. Nigeria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 8.4.3.2. Nigeria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 8.4.3.3. Nigeria Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 8.4.4.2. Rest of ME&A Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 8.4.4.3. Rest of ME&A Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 9. South America Neurovascular Devices/Interventional Neurology Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 9.2. South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 9.3. South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry(2024-2032) 9.4. South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Country (2024-2032) 9.4.1. Brazil 9.4.1.1. Brazil Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 9.4.1.2. Brazil Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 9.4.1.3. Brazil Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 9.4.2. Argentina 9.4.2.1. Argentina Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 9.4.2.2. Argentina Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 9.4.2.3. Argentina Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Product (2024-2032) 9.4.3.2. Rest Of South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by Type (2024-2032) 9.4.3.3. Rest Of South America Neurovascular Devices/Interventional Neurology Market Size and Forecast, by End-use Industry (2024-2032) 10. Company Profile: Key Players 10.1. Stryker Corporation 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Medtronic plc 10.3. Johnson & Johnson 10.4. Terumo Corporation 10.5. Penumbra, Inc 10.6. Abbott Laboratories 10.7. Merit Medical Systems, Inc 10.8. W.L Gore & Associates, Inc 10.9. Microport Scientific Corporation 10.10. B.Braun Melsungen AG 10.11. Cook 10.12. Uresil, LLC 10.13. Medikit Co Ltd 10.14. Bayer AG 10.15. Acandis GmbH 10.16. Biosensors International group Ltd 10.17. Integra Life sciences Corporation 10.18. Others 11. Key Findings 12. Industry Recommendations 13. Neurovascular Devices/Interventional Neurology Market: Research Methodology 14. Terms and Glossary
